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Sara K. Pasquali,1 MD, MHS, and Aimee Armstrong,1 MD
Objectives: We evaluated the use of, and outcomes associated with, balloon angio-
plasty (BA) for recurrent coarctation in single ventricle (SV) and two ventricle (2V)
patients following a Norwood-type aortic arch reconstruction (NTAR). Background:
Extended patch augmentation of the aorta, a NTAR, is utilized in SV patients under-
going the Norwood procedure (NP) as well as 2V patients with a diffusely hypoplastic
aorta. While many studies have evaluated recurrent coarctation following the NP, the
incidence of recurrent coarctation and outcomes associated with BA in 2V patients fol-
lowing NTAR are unclear. Methods: A retrospective review was performed of all neo-
nates who underwent a NTAR at our institution between 2000 and 2010. The incidence
of recurrent coarctation requiring intervention and factors associated with successful
BA were evaluated. Results: A NTAR was performed in 361 SV patients and 88 2V
patients. The incidence of recurrent coarctation requiring intervention was 19.3% in 2V
vs. 9.7% in SV patients (P5 0.01) at a median of 0.5 (interquartile range 0.3–1.2) years
from initial surgery. BA was successful in 25 SV patients (81%) and 10 2V patients
(71%; P5 0.70). Of the characteristics evaluated, lower initial peak-to-peak gradient
(P5 0.02), larger balloon size for angioplasty (P5 0.02) and larger diameter of the de-
scending aorta (P5 0.01) were associated with BA success. Conclusions: Recurrent
coarctation following NTAR is more common in 2V patients than in SV patients. BA for
recurrent coarctation has similar success in both groups and should continue to be
utilized in this population. VC 2013 Wiley Periodicals, Inc.
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INTRODUCTION
Recurrent aortic coarctation is a relatively common
complication following the Norwood procedure (NP)
as part of the surgical palliation of single ventricle
(SV) anatomy. The incidence of recurrent coarctation
following the NP varies widely in the literature, from 2
to 40% [1–11], and balloon angioplasty (BA) has been
shown to be an effective therapy for relief of recurrent
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coarctation in this setting with success rates upward of
85% [3,5,7,11–13]. Few factors have been consistently
identified to be associated with an increased risk of
recurrent coarctation [1,9,14,15], and there is even
more uncertainty as to factors associated with the suc-
cess or failure of BA in these patients [11,12].
Increased familiarity with the NP in SV patients has
allowed translation of a similar technique of aortic
reconstruction to the repair of two ventricle (2V)
patients with complicated aortic arch anatomy necessi-
tating more extensive aortic arch repair [16,17]. In our
center, extended patch augmentation of the aorta in a
manner similar to the NP is referred to as a Norwood-
type aortic arch reconstruction (NTAR). The incidence
of recurrent coarctation following this type of repair
has been reported in only one small series [17] and
outcomes of BA in this population have not been pre-
viously described. The aim of this study was to evalu-
ate the use, timing, and midterm outcomes associated
with BA in 2V and SV patients following NTAR and
to describe factors associated with BA success.
METHODS
Study Population
SV and 2V neonates, less than 1 month of age, who
underwent a NP or NTAR, respectively, at the Univer-
sity of Michigan Congenital Heart Center between Jan-
uary 2000 and December 2010 were identified using
the institutional cardiac surgical database. For this
study, a NTAR was defined as extended patch augmen-
tation of the underside of the aorta, extending across
the transverse arch, utilizing a median sternotomy and
cardiopulmonary bypass. Patients were excluded if
they died within 1 month of the initial surgery or had
less than 1 month of follow-up available after their ini-
tial surgery. Patients who developed significant recur-
rent coarctation requiring intervention (either catheter
based or surgical) were identified by utilizing the Elec-
tronic Medical Record Search Engine (EMERSE) sys-
tem. EMERSE is a web-based tool used to search
patient specific information in the University of Michi-
gan Clinical Data Repository, which includes medical
documentation from inpatient and outpatient records
and allows for automated searches of specific
keywords. Using EMERSE, the medical record was
searched for the terms “recurrent coarctation,”
“recoarctation,” “aortic arch obstruction,” “aortic arch
gradient,” “residual arch obstruction,” and “ascending
aortic stenosis.” There were no defined parameters to
determine the need for intervention and therefore
the decision to intervene was at the discretion of the
clinical team and made on a case-by-case basis as
determined by clinical status, arch gradient, and angio-
graphic appearance of the aorta. Patients who had
intervention for recurrent coarctation performed at an
outside institution were included in determination of
recurrent coarctation rate but were excluded from fur-
ther analysis, as procedural data from the intervention
was unavailable.
Data Collection
Retrospective review of the medical record was per-
formed, and preoperative, operative, and echocardio-
graphic data were collected. Angiographic images for
those who underwent cardiac catheterization were
reviewed and measurements made using AP and
lateral images, as available. For patients with recurrent
coarctation, additional data including pre- and post-
intervention echocardiogram results and procedural
characteristics were reviewed. For patients who under-
went BA, coarctation index, defined as the ratio of the
narrowest arch dimension and the diameter of the aorta
at the diaphragm [18], and ratios of the smallest to
largest arch dimensions, angioplasty balloon size to the
narrowest arch dimension, and angioplasty balloon size
to the diameter of the aorta at the diaphragm, were cal-
culated, and location (proximal or distal to the left sub-
clavian artery) and type of coarctation (discrete or long
segment) were recorded. Intervention was considered
acutely successful if the peak-to-peak aortic arch gradi-
ent by catheterization was 10 mm Hg [5,8] in SV
patients and 15 mm Hg in 2V patients and was deter-
mined retrospectively based upon institutional preferen-
ces. Subsequent recoarctation and time to last available
follow-up or death were recorded on all patients. The
University of Michigan Institutional Review Board
approved this protocol with waiver of informed con-
sent.
Statistical Analysis
Data are presented as frequency with percentage for
categorical variables and median with interquartile
range (IQR), or mean6 standard deviation, as appro-
priate, for continuous variables. Group comparisons
between SV and 2V groups were made using chi-
square test or Fisher’s exact test for categorical varia-
bles and Wilcoxon rank-sum test or t test for continu-
ous variables. Similarly, clinical and procedural
characteristics were also compared between patients
with BA success and those with BA failure to deter-
mine potential factors associated with success of BA.
Due to small sample size, the SV and 2V groups were
combined for this comparison. Freedom from recurrent
coarctation after initially successful BA was computed
using Kaplan–Meier method. All analyses were per-
formed using SAS Version 9.3 (SAS Institute, Cary,
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NC), with statistical significance set at a P value
<0.05 using a two-sided test.
RESULTS
Study Population
A total of 600 patients were identified as having a
NTAR during the study period. After applying the exclu-
sion criteria, 449 neonates were included in the final
study population. A flow diagram outlining the short-term
outcomes of these patients are displayed in Fig. 1. The
clinical characteristics of patients who underwent inter-
vention for recurrent coarctation are shown in Table I.
Recurrent Coarctation
A total of 35 SV patients (9.7%) and 17 2V patients
(19.3%) required intervention for recurrent coarctation
(P¼ 0.01). In 46 patients (88%) the intervention was a
planned procedure with recurrent coarctation suspected
by echocardiogram. Preprocedural characteristics of the
46 patients who had BA performed at our center are listed
in Table II. SV and 2V groups had similar initial aortic
arch gradients as measured by catheterization (P¼ 0.11)
but 2V patients had a significantly higher peak instantane-
ous pressure gradients by echocardiogram (P¼ 0.001).
All 2V patients had normal systemic ventricular function
by echocardiogram compared with eight patients (26%)
in the SV group who had at least moderately depressed
systemic ventricular function (P¼ 0.04). While there was
a trend toward patients with better ventricular function
having higher aortic arch gradients, this association was
not significant. Likely a reflection of the larger proximal
patch created in SV patients to allow for the anastomosis
of the two native outflow tracts, SV patients had higher
largest aortic arch dimensions (P¼ 0.01).
BA for Recurrent Coarctation
All but 2 patients underwent BA as the primary inter-
vention for recurrent coarctation at a median of 0.5 years
(IQR 0.3–1.2) from their initial surgery. The two patients
who had surgery as their primary intervention were SV
patients and were repaired surgically because of long
segment stenosis in one case and because of a concomi-
tant surgery for another indication in the second case. A
retrograde approach for BA through the femoral artery
was used in 37 (80%) of patients with an antegrade
approach performed in nine SV patients.
Acute success with BA was achieved in 25 SV
patients (81%) and 10 2V patients (71%; P¼ 0.70). Pro-
cedural characteristics of the SV and 2V patients are
compared in Table II. Median balloon size chosen was
106% of the descending aortic diameter at the diaphragm
with a significantly higher ratio in SV compared with
2V patients (median 109%, IQR 100–129% and median
100%, IQR 80–106%, respectively; P¼ 0.03). Balloon
size was 2.2 times the narrowest aortic arch dimension
in both groups. There was a reduction in gradient by a
median of 83% (IQR 100 to 64) in the SV patients
and 74% (IQR 85 to 55) in the 2V patients
(P¼ 0.12). There were six patients who had procedural
complications (13%); five SV patients (16%) and one
2V patient (6.7%). Complications included transient
heart block, bradycardia/hypotension requiring resuscita-
tion, respiratory depression as a result of anesthesia, and
death. The one procedural death occurred in a 2V patient
with preexisting sepsis who was referred for emergent
BA. Catheter perforation, pericardial tamponade, and
death occurred during the diagnostic portion of the case
and BA was not performed. Two patients had small inti-
mal tears noted by postangioplasty angiogram but no
patient required intervention or had aneurysm develop-
ment during the follow-up period. No patient had femo-
ral vessel complications.
Factors Associated With Outcome of BA
Association of clinical and procedural characteris-
tics with outcome of BA by univariate analysis is
shown in Table III. Due to small sample size, the
2V and SV groups were combined for this analysis
and multivariable analysis was not performed.
Among the 45 patients who underwent BA at our
Fig. 1. Flow diagram showing the short-term outcomes of
the included study patients.
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center and had postintervention aortic arch gradients
available, male sex, lower initial peak-to-peak gradi-
ent measured during catheterization, and larger
diameter of the descending aorta at the diaphragm
were significantly associated with BA success.
While balloon type was not associated with angio-
plasty success (89% used a Tyshak II balloon
[NuMED, Hopkinton, NY]), balloon size was associ-
ated with success (Table III).
Additional Outcomes
Over a median follow-up period of 2.3 years (IQR
1.6–5.3) since initial surgery, subsequent recoarctation
following an initially successful BA occurred in four
SV patients (11%). Time to subsequent recoarctation
encompassed a wide range from 5.4 months to 9.7
years with all but one case occurring within the first
15 months after initial intervention. Freedom from
recurrent coarctation after initially successful BA is
shown in Fig. 2. The four patients who had an initially
successful BA with subsequent development of
recoarctation, had a repeat BA performed. Of the 10
unsuccessful BA procedures, 2 patients did not undergo
repeat intervention, 1 patient underwent repeat BA pro-
cedure at 42 days after their initial procedure, and 7
patients proceeded with surgical arch intervention at a
median of 6 days (range from 1 day to 50 days) after
their initial BA procedure.
DISCUSSION
This study, evaluating recurrent coarctation in both
univentricular and biventricular NTAR, found rates of
recurrent coarctation of 19.3% in the 2V population
and 9.7% in the SV population. Despite this difference,
however, BA was shown to be equally effective in
relief of recurrent coarctation with combined success
rates in the SV and 2V groups of 78%. In this com-
bined population, lower initial peak-to-peak gradient,
larger diameter of the aorta at the diaphragm, and
larger angioplasty balloon size were identified as being
associated with BA success.
TABLE I. Patient and Clinical Characteristics of Neonates Who Underwent Any Intervention for Recurrent Coarctation Follow-
ing NTARa
Characteristics All (N¼ 52)
Type of anatomy
P valuebSV (N¼ 35) 2V (N¼ 17)
Male sex 28 (53.8) 18 (51.4) 10 (58.8) 0.62
Premature (less than 37 weeks) 10 (19.2) 6 (17.1) 4 (23.5) 0.71
Diagnosis for SV patients
HLHS 28 (80.0)
Other systemic right ventricle 4 (11.4)
Other systemic left ventricle 3 (8.6)
Type of initial shunt in SV patients
Blalock–Taussig shunt 23 (65.7)
RV-PA shunt 11 (31.4)
Central 1 (2.9)
Stage II completed 32 (91.4)
Fontan completed 26 (74.3)
Diagnosis for 2V patients
Interrupted aortic arch (IAA) 7 (41.2)
Coarctation/arch hypoplasia 8 (47.1)
Other 2 (11.8)
Type of 2V repair
Arch reconstruction alone 11 (64.7)
Arch reconstruction and Rastelli 3 (17.6)
Arch reconstruction and arterial switch operation 3 (17.6)
Smallest aortic arch dimension (by echo; N¼ 32; mm) 2.0 (1.7–2.4) 2.0 (1.6–2.6) 2.0 (2.0–2.0) 0.63
Surgical factors
Age at (initial) surgical repair (days) 7 (5–9) 6 (5–8) 8 (6–13) 0.03
Weight at (initial) surgical repair (kg) 3.16 0.6 3.16 0.6 2.96 0.8 0.36
Cardiopulmonary bypass time (min) 85 (67.5–111.5) 82 (67–96) 110 (68–165) 0.23
Follow-up
Deceased 8 (15.4) 6 (17.1) 2 (11.8) 1.00
Abbreviations: SV, single ventricle; 2V, two ventricle; HLHS, hypoplastic left heart syndrome; RV-PA, right ventricle to the main pulmonary artery.
aData are presented as N (%) for categorical variables and median (interquartile range) or mean6 standard deviation, for continuous variables.
bP value from chi-square test or Fisher’s exact test, for categorical variables, and Wilcoxon rank-sum test or t test, for continuous variables, for com-
parison between SV and 2V patients.
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The incidence of recurrent coarctation found in our
study is comparable to the reported rates of 4–20%
across various types of arch repairs in 2V patients
[17,19–26] and 2–40% reported from numerous studies
in SV patients following the NP [1–6,9–11,27]. Our
study is unique, however, in evaluating these groups
TABLE II. Preprocedural and Procedural Characteristics of Neonates Who Underwent Balloon Angioplasty as Intervention for
Recurrent Coarctation Following NTARa
Characteristics All (N¼ 46)
Type of ventricle
P valuebSingle V (N¼ 31) Two V (N¼ 15)
Weight at intervention (N¼ 41; kg) 6.4 (5.1–9.6) 6.4 (4.7–9.6) 6.3 (5.4–13.4) 0.65
Location of coarctation
Proximal 5 (10.9) 3 (9.7) 2 (13.3) 0.64
Distal 40 (87.0) 28 (90.3) 12 (80.0)
Coarctation segment type
Discrete 40 (87.0) 27 (87.1) 13 (86.7) 1.00
Long 5 (10.9) 4 (12.9) 1 (6.7)
Preprocedure PIPG by echocardiogram 40 (18–64) 36 (21–44) 64 (50–75) 0.001
Initial cath peak-to-peak gradient (mm Hg) 27 (20–40) 26 (15–34) 35 (25–48) 0.11
Largest balloon size (mm) 8 (7–12) 8 (7–12) 8 (6–9) 0.10
Aortic arch dimensions by angiography (mm)
Narrowest 3.7 (2.5–5) 3.6 (2.7–5.5) 3.9 (1.7–4.5) 0.41
Largest 14 (12.5–17.5) 17 (13–20) 12 (10.8–14) 0.01
Diameter of DAO at diaphragm 7.8 (6.3–10) 7.8 (6.7–10) 8 (6–10) 0.80
Coarctation index 0.46 (0.38–0.57) 0.49 (0.42–0.58) 0.39 (0.34–0.44) 0.04
Postprocedure peak-to-peak gradient (mm Hg) 5 (0–12) 2 (0–10) 10.5 (5–20) 0.02
Abbreviations: DAO, descending aorta; PIPG, peak instantaneous pressure gradient.
aData are presented as N (%) for categorical variables and median (interquartile range) for continuous variables.
bP value from Fisher’s exact test for categorical variables and Wilcoxon rank-sum test for continuous variables on comparison between SV and 2V
patients.
TABLE III. Association of Clinical and Procedural Characteristics With Outcome of Balloon Angioplasty by Univariate Analysisa
Characteristics
Success of balloon angioplasty
P valuebYes (N¼ 35) No (N¼ 10)
Male sex 23 (65.7) 1 (10.0) 0.003
Age at (initial) surgical repair (days) 7 (5–11) 6.5 (5–8) 0.96
Weight at (initial) surgical repair (kg) 3.26 0.6 2.86 0.8 0.14
Cardiopulmonary bypass time (min) 86 (67–112) 80 (71–98) 0.59
Intervention with balloon angioplasty
Age at intervention (years) 0.5 (0.4–1.3) 0.4 (0.3–1.1) 0.27
Weight at intervention (N¼ 41; kg) 6.6 (5.1–10.9) 5.7 (4.6–7.1) 0.51
Location of coarctation
Proximal 2 (5.7) 3 (30.0) 0.06
Distal 33 (94.3) 7 (70.0)
Coarctation segment type
Discrete 32 (91.4) 8 (80.0) 0.31
Long 3 (8.6) 2 (20.0)
Initial peak-to-peak gradient (mm Hg) 26 (15–34) 44 (26–60) 0.02
Largest balloon size 8 (7–12) 7 (6–8) 0.02
Aortic arch dimensions (mm)
Narrowest 3.9 (2.7–5.7) 3.0 (2.0–3.9) 0.06
Diameter of DAO at diaphragm 8.5 (6.7–10) 6.5 (5.0–7.0) 0.01
Coarctation index 0.46 (0.39–0.58) 0.46 (0.34–0.54) 0.69
Ratio of balloon size/narrowest aortic diameter 2.16 (1.79–3.03) 2.60 (2.05–3.04) 0.34
Ratio of balloon size/DAO diameter 1.06 (0.91–1.20) 1.05 (1.00–1.14) 0.60
Abbreviation: DAO, descending aorta.
aData are presented as N (%) for categorical variables and median (interquartile range) or mean6 standard deviation, as appropriate, for continuous
variables.
bP value from Fisher’s exact test for categorical variables and Wilcoxon rank-sum test or t test for continuous variables on comparison between
patients with/without success of balloon angioplasty.
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across the same time period using the same group of
surgeons and thereby minimizing the effect of varia-
tions in surgical technique. While the aortic arch repair
may be similar between the SV and 2V groups, differ-
ences in intracardiac anatomy remain which may affect
flow patterns and aortic growth in ways that cannot be
measured by the clinical factors evaluated in this study
and which may account for the different recurrent co-
arctation rates found here between the two groups.
Despite these anatomic differences, BA on a similar
type of arch repair was expected to have similar techni-
cal success between the SV and 2V groups and, in fact,
BA is shown in this study to have similarly high suc-
cess rates in both groups. Variability in the definition
of BA success makes it difficult to compare our results
directly with prior studies, however our results are com-
parable to the 74–90% reported in 2V patients follow-
ing an assortment of traditional aortic arch repairs
[13,28–30] and 85–100% success for SV patients fol-
lowing the NP [5,7,8,11,12]. We chose two separate re-
sidual pressure gradients to define success in the SV
and 2V groups as it is our practice to intervene at a
lower residual gradient in SV patients who presumably
have a limited ability to tolerate residual obstruction.
While success rates of BA are high, 31% of the
patients who underwent BA as a primary intervention
for recurrent coarctation either had an unsuccessful BA
or had subsequent recoarctation requiring an additional
intervention. Similar to previous studies, however, our
study also has shown that it is difficult to predict which
patients may be at higher risk for BA failure. A recent
study by Bendaly et al. [11] of 39 patients with recurrent
coarctation following the NP found that increased pre-
procedure gradient and increased ratio of balloon size to
size of the descending aorta were associated with BA
success. An earlier multicenter study by Soongswang
[12] found that earlier time of intervention, increased
preprocedure gradient, and increased balloon to coarcta-
tion ratio were associated with an increased absolute
reduction in peak-to-peak gradient. We found no associa-
tion with patient age, size, or time from initial surgical
procedure with BA success. Increased balloon size,
whether this suggests a relatively less severe recoarcta-
tion or oversizing of the balloon, is the only factor that
seems to be consistent among studies and therefore it
remains difficult to guide the choice of intervention and
to further prevent development of recurrent coarctation.
Limitations
Identification of recurrent coarctation was limited to
those receiving intervention and therefore patients with
unrecognized coarctation or patients who died prior to
intervention would be missed. In addition, patients
were excluded if they underwent intervention for recur-
rent coarctation at an outside institution or if they did
not have at least 1 month of follow-up available which
may have introduced some selection bias in the study
population. Finally, due to the small number of angio-
plasty patients, analysis of factors associated with BA
outcomes could only be analyzed with the 2V and SV
groups combined. While outcomes of BA in the two
groups were similar, clinical factors including preoper-
ative and postoperative anatomy were markedly differ-
ent between groups and may have diluted the results of
our risk factor analysis.
Conclusions
In summary, while the aortic reconstruction of the
NP and NTAR are similar, there are differences in the
residual intracardiac anatomy and postoperative physi-
ology between these groups which may affect out-
comes. Despite these differences, BA is a valuable
intervention for relief of recurrent obstruction in both
groups with high success rates and few complications.
There are no identifiable preprocedural factors and lim-
ited intraprocedural factors that predict successful BA
but it is still reasonable to attempt BA as first-line
intervention in both groups of patients, prior to consid-
eration of surgical repair.
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